Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Insilico Medicine, an early force in AI-driven drug R&D, lets IPO plans peter out for second year in a row
9 months ago
Financing
Startups
Gilead's Kite uncouples from Fosun in China as Yescarta faces coverage obstacles
9 months ago
Deals
Congress spars over whether the Biosecure Act is an overdue crackdown or a rushed witch hunt
10 months ago
FDA+
Manufacturing
House passes Biosecure Act, sending Chinese biotech ban to Senate
10 months ago
Manufacturing
Law
Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success
10 months ago
Financing
Startups
Summit's Phase 3 data back up biotech's boasts of beating Keytruda in lung cancer
10 months ago
R&D
Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote
10 months ago
Deals
R&D
Little-known startup, backed by Foresite and Samsara, swings $60M China I&I deal
10 months ago
Startups
Deals
Biosecure vote slated for September
10 months ago
FDA+
Law
Sanofi pauses supply of two flu vaccines in China over ‘unexpected circumstances’
10 months ago
Pharma
Manufacturing
Duality Biologics, an ADC partner of BeiGene and BioNTech, files for Hong Kong IPO
10 months ago
Financing
Startups
Mubadala, CBC Group ink $680M deal for UCB’s neurology and allergy portfolio in China
10 months ago
Deals
Pharma
Updated: Chinese government indicts Japanese Astellas employee for espionage
10 months ago
People
WuXi Bio spotlights new US contracts, but profits are down as Biosecure brews
10 months ago
Manufacturing
Indian CDMOs unlikely to see sudden surge in clients if China bill passes, execs say
10 months ago
Manufacturing
WuXi Biologics’ ADC spinout reports revenue jump despite Biosecure risk
10 months ago
Manufacturing
House lawmakers call on FDA to investigate clinical trials run alongside China's military
10 months ago
FDA+
BioNTech, MediLink to resume trial enrollment for HER3 antibody-drug conjugate after FDA pause
10 months ago
R&D
TYK Medicines seeks to launch new EGFR drug in China with $74M Hong Kong IPO
10 months ago
Financing
Pressure from anti-China legislation begins to ripple through biopharma
11 months ago
Pharma
Manufacturing
Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody
11 months ago
Deals
Pharma
WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US
11 months ago
Manufacturing
Weak China demand weighs on Illumina's sales
11 months ago
Diagnostics
Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China
11 months ago
Startups
Deals
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page